- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Antibody–drug conjugates in solid tumors: a look into novel targets ; volume:14 ; number:1 ; day:28 ; month:1 ; year:2021 ; pages:1-18 ; date:12.2021
Journal of hematology & oncology ; 14, Heft 1 (28.1.2021), 1-18, 12.2021
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-021-01035-z
- URN
-
urn:nbn:de:101:1-2021032121254276121476
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Criscitiello, Carmen
- Morganti, Stefania
- Curigliano, Giuseppe
- SpringerLink (Online service)
Other Objects (12)
Antibody–drug conjugates in ovarian cancer
Antibody–drug conjugates—the magic bullet?
Antibody–Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A Review
Fate of Antibody-Drug Conjugates in Cancer Cells
Antibody–drug conjugates (ADCs) in lung cancer treatment
Ethynylphosphonamidates in the Synthesis of Antibody–Drug Conjugates
Safety and Tolerability of Antibody-Drug Conjugates in Cancer
Potential of antibody–drug conjugates (ADCs) for cancer therapy
Antibody–drug conjugates in the treatment of lymphoid neoplasms
Antibody–drug conjugates as an emerging therapy in oncodermatology
Research progress of antibody–drug conjugates in gynecologic cancer
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
Antibody–drug conjugates in ovarian cancer
Antibody–drug conjugates—the magic bullet?
Antibody–Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A Review
Fate of Antibody-Drug Conjugates in Cancer Cells
Antibody–drug conjugates (ADCs) in lung cancer treatment
Ethynylphosphonamidates in the Synthesis of Antibody–Drug Conjugates
Safety and Tolerability of Antibody-Drug Conjugates in Cancer
Potential of antibody–drug conjugates (ADCs) for cancer therapy
Antibody–drug conjugates in the treatment of lymphoid neoplasms
Antibody–drug conjugates as an emerging therapy in oncodermatology
Research progress of antibody–drug conjugates in gynecologic cancer
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
Antibody–drug conjugates in ovarian cancer
Antibody–drug conjugates—the magic bullet?
Antibody–Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A Review
Fate of Antibody-Drug Conjugates in Cancer Cells
Antibody–drug conjugates (ADCs) in lung cancer treatment
Ethynylphosphonamidates in the Synthesis of Antibody–Drug Conjugates
Safety and Tolerability of Antibody-Drug Conjugates in Cancer
Potential of antibody–drug conjugates (ADCs) for cancer therapy
Antibody–drug conjugates in the treatment of lymphoid neoplasms
Antibody–drug conjugates as an emerging therapy in oncodermatology
Research progress of antibody–drug conjugates in gynecologic cancer